Exactech Faces Bankruptcy: Implications for Joint Replacement Patients
Exactech Faces Bankruptcy: Implications for Joint Replacement Patients
Exactech, Inc., recognized for its design and manufacture of joint replacement implants and surgical instruments, has recently notified the public about its bankruptcy proceedings. This announcement has significant implications for individuals who have had hip, knee, or other joint replacements using Exactech products.
The company, along with its affiliates, has filed voluntary Chapter 11 petitions in the Bankruptcy Court for the District of Delaware, marking a critical juncture in its operational history. As part of the bankruptcy proceedings, Exactech plans to sell nearly all of its assets, which raises questions about the future of its product lines, including widely used implants like Optetrak, Truliant, and Equinoxe.
Who Should Pay Attention?
If you have undergone a joint replacement or received an implant from Exactech, it's essential to review this notice thoroughly. Your legal rights may be impacted by the company’s financial status and the asset sale process. Exactech manufactures various implants, such as those for the knee, hip, shoulder, and ankle, which play a crucial role in enhancing the quality of life for countless individuals.
What Products Are Affected?
The key devices involved in these proceedings include:
- - Optetrak - a knee replacement system known for its innovative design.
- - Truliant - which aims to provide improved functionality.
- - Connexion GXL - another joint replacement option.
- - And others like Vantage and Equinoxe.
File Your Proof of Claim
If you have benefited from an Exactech implant or other product, it is crucial to file a Proof of Claim. This process ensures you receive any potential compensation following the bankruptcy proceedings. Claims can be submitted online through EXTclaims.com, or via US Mail to the Exactech Claims Processing Center by the deadline of February 7, 2025 at 4:00 p.m. ET. It’s critical to remember that failing to submit a claim by this date may result in forfeiting your rights to any compensation.
How to Object to the Asset Sale
As part of the bankruptcy case, Exactech’s intention to sell its assets is another factor that may influence your rights. If you anticipate your interests could be adversely affected, you can file an objection. Objections must be submitted by March 18, 2025 at 4:00 p.m. ET and should align with the Bankruptcy Rules and local regulations. Detailed instructions on filing these objections are also available on EXTclaims.com.
Upcoming Hearing Date
The next significant date in this process is the Asset Sale Hearing scheduled for March 27, 2025, at 10:00 a.m. ET. This hearing will be held before Judge Silverstein in the Wilmington Bankruptcy Court, allowing stakeholders to voice their concerns and present their cases regarding the planned sale.
As the situation unfolds, affected individuals are encouraged to stay informed and take the necessary steps to protect their rights. The bankruptcy filing represents a pivotal moment for Exactech and its stakeholders, particularly those who rely on the company’s joint replacement products.
For further questions or guidance, affected individuals can call the dedicated lines for assistance: 833.918.0986 (US/Canada Toll-Free), +1.646.781.8728 (International), or +61 (2) 72.094.837 (Australia).
Stay vigilant and proactive in monitoring this situation as developments occur, ensuring that your legal rights are adequately safeguarded during these proceedings.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.